// App-Quantinova.ai

GW26-e3551 : Plaque Thrombosis Are Reduced by Attenuating Plaque Inflammation with Pioglitazone and Are Evaluated by Fluorodeoxyglucose Positron Emission Tomography

Researchers

Presenter

  • Mingduo Zhang

Principal Investigators

  • Shuzheng Lv

  • Quanming Zhao

Medical Centers

  • Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • High sensitivity C-reactive protein

  • Matrix metallopeptidase 9

Drug/Treatment

  • Pioglitazone

  • Actoplus Met XR extended-release tablet

  • Fludeoxyglucose (18F)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved